Australia markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
160.50-2.34 (-1.44%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 564.28B
Enterprise value 360.73B
Trailing P/E N/A
Forward P/E 19.16
PEG ratio (5-yr expected) 10.44
Price/sales (ttm)80.02
Price/book (mrq)24.99
Enterprise value/revenue 375.59
Enterprise value/EBITDA 7-82.97

Trading information

Stock price history

Beta (5Y monthly) 1.46
52-week change 3174.84%
S&P500 52-week change 342.25%
52-week high 3189.26
52-week low 346.13
50-day moving average 3151.97
200-day moving average 3133.31

Share statistics

Avg vol (3-month) 39.72M
Avg vol (10-day) 312.79M
Shares outstanding 5400.52M
Implied shares outstanding 6N/A
Float 340.3M
% held by insiders 19.73%
% held by institutions 154.77%
Shares short (14 Apr 2021) 411.84M
Short ratio (14 Apr 2021) 41.39
Short % of float (14 Apr 2021) 44.05%
Short % of shares outstanding (14 Apr 2021) 42.96%
Shares short (prior month 14 Mar 2021) 414.97M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin -92.99%
Operating margin (ttm)-94.99%

Management effectiveness

Return on assets (ttm)-10.69%
Return on equity (ttm)-39.99%

Income statement

Revenue (ttm)803.4M
Revenue per share (ttm)2.11
Quarterly revenue growth (yoy)3,960.80%
Gross profit (ttm)-574.88M
EBITDA -731.89M
Net income avi to common (ttm)-747.06M
Diluted EPS (ttm)-1.96
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.61B
Total cash per share (mrq)11.53
Total debt (mrq)237.6M
Total debt/equity (mrq)9.28
Current ratio (mrq)1.43
Book value per share (mrq)6.42

Cash flow statement

Operating cash flow (ttm)2.03B
Levered free cash flow (ttm)2.19B